Background Sinonasal neoplasms, whether benign and malignant, pose a significant
challenge to clinicians and represent a model area for multidisciplinary collaboration in …

Intensity‐modulated radiation therapy (IMRT), an advent of three‐dimensional conformal
radiotherapy (3D CRT), has excited the profession of radiation oncology more than any …

Introduction Many controversies exist in the diagnosis and management of this aggressively
malignant condition, mainly because of limited literature and lack of randomized control …

Background. Olfactory neuroblastoma (ONB) is a rare tumor arising from the olfactory
neuroepithelium. There is no universally accepted staging system, and treatment …

Abstract Objectives/Hypothesis: This study reviews the published outcomes related to
surgical (open, endoscopic, and endoscopic‐assisted) and nonsurgical treatment for …

BACKGROUND Sinonasal neuroendocrine tumors are rare malignancies that are
represented by a spectrum of histologies, including esthesioneuroblastoma (ENB) …

Objective To consider the long‐term survival and outcomes in patients with olfactory
neuroblastoma undergoing craniofacial resection. Study Design A single‐center prospective …

Sinonasal tumors are rare diseases, accounting for 3% to 5% of head and neck malignant
neoplasms and the 0.2% to 0.8% of all tumors. 1 There are several histologic subtypes with …

Objectives To analyze outcomes and to provide follow-up for our increasing patient cohort
with esthesioneuroblastoma. Design Retrospective cohort analysis. Setting Patients were …

Introduction Malignant sinonasal tumors comprise less than 1% of all neoplasms. A wide
variety of tumors occurring primarily in this site can present with an undifferentiated or poorly …